RRx-001 Sequentially With a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond in Patients With Small Cell Lung Cancer
Clinical trial NCT03699956 · TERMINATED
Trial details
- NCT number
- NCT03699956
- Sponsor
- EpicentRx, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-24
- Primary completion
- 2022-08-11
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.